Full name
"SCANVET POLAND" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
10.86.Z - Production of homogenized food products and diet food
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
68.20.Z - Rental and management of own or leased real estate
69.20.Z - Accounting, bookkeeping and tax consultancy
73.20.Z - Market research and public opinion polling
75.00.Z - Veterinary activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,2 | 1 | 314,1 |
EBITDA | 0,6 | 0,4 | 1,1 | 178 |
Short time liabilities | 0,9 | 1 | 0,9 | -11,8 |
Equity capital | 11,8 | 10 | 10,8 | 7,6 |
Operating profit (EBIT) | 0,4 | 0,2 | 1 | 315,9 |
Assets | 12,7 | 11 | 11,7 | 5,9 |
Net profit (loss) | 0,3 | 0,2 | 0,8 | 331,5 |
Cash | 7,1 | 4,1 | 4 | -1,3 |
Liabilities and provisions for liabilities | 0,9 | 1 | 0,9 | -11,8 |
Net income from sale | 35,9 | 36,2 | 40 | 10,5 |
Working assets | 11,3 | 9,7 | 10,3 | 6,1 |
Depreciation | 0,2 | 0,2 | 0,2 | -8,3 |
% | % | % | p.p. | |
Profitability of capital | 2,9 | 1,8 | 7,1 | 5,3 |
Equity capital to total assets | 92,8 | 91,1 | 92,6 | 1,5 |
Gross profit margin | 1,2 | 0,6 | 2,4 | 1,8 |
EBITDA Margin | 1,7 | 1,1 | 2,8 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 9 | 10 | 8 | -2 |
Current financial liquidity indicator | 12.321111679077148 | 9.886312484741211 | 11.89099407196045 | 2 |
Net dept to EBITDA | -11.32423210144043 | -10.159220695495605 | -3.6082520484924316 | 6,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane